SCHEMBL7821696

SCHEMBL7821696

Cc1cn(CCCCl)c(=O)n(-c2ccc(F)cc2)c1=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
RAB9A P51151 1/20 0.37
MET P08581 4/20 0.35
ADORA2B P29275 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HKDC1 Q2TB90 2/20 0.34
POLB P06746 1/20 0.34
TP53 P04637 1/20 0.34
AXL P30530 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830819 0.86 PGR (0.43) GSK3AGSK3BNPC1RAB9AADORA2B
SCHEMBL26756058 0.81 KDM4E (0.44) GSK3AGSK3BKDM4EMETSMN1; SMN2
SCHEMBL7821435 0.76 KDM4E (0.42) KDM4ETP53
SCHEMBL26034601 0.75 POLB (0.38) NPC1CYP2C19METPOLBAXL
SCHEMBL2349445 0.70 ADORA2B (0.51) KDM4EADORA2BPOLBTP53RXFP1
SCHEMBL23749476 0.70 MET (0.47) METAXLL3MBTL1
SCHEMBL14969202 0.69 MET (0.48) KDM4ENPC1CYP2C19CYP1A2CYP2C9
SCHEMBL7830310 0.69 MEN1 (0.48) RAB9AADORA2BSMN1; SMN2L3MBTL1
SCHEMBL23749405 0.69 GSK3A (0.37) GSK3AGSK3BKDM4ENPC1RAB9A
SCHEMBL14969007 0.68 MET (0.47) KDM4EMETAXLL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed